PHARMACEUTICAL AGENTS FOR THE TREATMENT OF CEREBRAL AMYLOIDOSIS
摘要
Formation of cerebral amyloid associated with Alzheimer's disease can be treated or averted using medicaments that are effective in vivo in preventing disruption of dense microspheres (DMS) or in altering the disruption so as to (i) reduce the volume of tissue occupied by redistributed, transformed DMS protein material and its associated injury focus; (ii) reduce the persistence or duration of injury and inflammation associated with the disrupted DMS and redistributed transformed DMS protein material; and/or (iii) increase the digestion and removal of DMS material through the reticuloendothelial system.
申请公布号
WO9852898(A9)
申请公布日期
1999.04.01
申请号
WO1998US10218
申请日期
1998.05.19
申请人
NYMOX CORPORATION;AVERBACK, PAUL;GHANBARI, HOSSEIN;BEHESHTI, IRAJ;MORSE, DAVID
发明人
AVERBACK, PAUL;GHANBARI, HOSSEIN;BEHESHTI, IRAJ;MORSE, DAVID